, Tracking Stock Market Picks
Enter Symbol:
Human Genome Sciences, Inc. (HGSI) [hlAlert]

up 136.31 %

Human Genome Sciences, Inc. (HGSI) rated Buy with price target $8 by Deutsche Securities

Posted on: Thursday,  Feb 21, 2008  12:25 PM ET by Deutsche Securities

Deutsche Securities rated Buy Human Genome Sciences, Inc. (NASDAQ: HGSI) on 02/21/2008. Previously Deutsche Securities rated Buy Human Genome Sciences, Inc. (NASDAQ: HGSI)
on 01/24/2008., when the stock price was $6.03. Since then, Human Genome Sciences, Inc. has gained 136.32% as of 08/01/2012's recent price of $14.25.
If you would have followed the previous Deutsche Securities's recommendation on HGSI, you would have gained 136.31% of your investment in 1651 days.

Human Genome Sciences is a biopharmaceutical company with a pipeline of novel compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. Additional products are in clinical development by companies with which we are collaborating. Its mission is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody products.

Deutsche Bank's award-winning Research team manages a range of functions from asset allocation, through economic forecasting across a broad range of industry sectors including cement and construction, chemicals, electronics, energy, engineering, machinery, media, software, tobacco, retailing and utilities, and oil and gas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/21/2008 12:25 PM Buy
6.38 8.00
as of 12/24/2008
1 Week down  -12.16 %
1 Month up  58.53 %
3 Months down  -35.96 %
1 YTD down  -38.67 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/24/2008 2:25 PM Buy
6.03 6.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy